Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR FamilySandra R. Brave, Simon T. Barry|Molecular Cancer Therapeutics|2011Cited by 88